Oncolytics Biotech Inc. (TSE:ONC - Get Free Report)'s stock price rose 10.1% during mid-day trading on Wednesday . The company traded as high as C$0.99 and last traded at C$0.98. Approximately 142,896 shares were traded during mid-day trading, an increase of 24% from the average daily volume of 115,398 shares. The stock had previously closed at C$0.89.
Analyst Upgrades and Downgrades
Separately, Jones Trading cut Oncolytics Biotech from a "strong-buy" rating to a "hold" rating in a report on Friday, May 16th.
View Our Latest Stock Analysis on Oncolytics Biotech
Oncolytics Biotech Trading Down 4.0%
The company has a quick ratio of 8.86, a current ratio of 2.99 and a debt-to-equity ratio of 11.75. The stock's 50 day moving average is C$0.69 and its 200-day moving average is C$0.95. The company has a market cap of C$74.76 million, a PE ratio of -2.70 and a beta of 1.35.
Oncolytics Biotech Company Profile
(
Get Free Report)
Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.
Recommended Stories
Before you consider Oncolytics Biotech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oncolytics Biotech wasn't on the list.
While Oncolytics Biotech currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
